Live Breaking News & Updates on Tscan Therapeutics Company Profile

Stay updated with breaking news from Tscan therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Needham & Company LLC Reaffirms "Buy" Rating for TScan Therapeutics (NASDAQ:TCRX)

Needham & Company LLC reiterated their buy rating on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a report issued on Monday, MarketBeat Ratings reports. They currently have a $11.00 price target on the stock. TCRX has been the topic of a number of other reports. Wedbush reissued an outperform rating and issued a […] ....

United States , Tscan Therapeutics Company Profile , Cannon Global Investment Management , Letko Brosseau Associates Inc , Needham Company , Tscan Therapeutics Inc , Free Report , Marketbeat Ratings , Therapeutics Trading Down , Get Free Report , Fire Capital , Global Investment Management , Therapeutics Company , Therapeutics Daily ,

TScan Therapeutics (NASDAQ:TCRX) Given Outperform Rating at Wedbush

Wedbush restated their outperform rating on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a research note published on Wednesday morning, RTT News reports. The firm currently has a $10.00 target price on the stock. Wedbush also issued estimates for TScan Therapeutics’ Q1 2024 earnings at ($0.27) EPS, Q2 2024 earnings at ($0.23) EPS, […] ....

United States , Tscan Therapeutics Company Profile , Renaissance Technologies , Tscan Therapeutics Inc , Blackrock Inc , Free Report , Therapeutics Stock , Get Free Report , Jane Street Group , Therapeutics Company , Therapeutics Daily , Tscan Therapeutics , Nasdaq Tcrx , Reiterated Rating ,

Pale Fire Capital SE Acquires Shares of 16,575 TScan Therapeutics, Inc. (NASDAQ:TCRX)

Pale Fire Capital SE Acquires Shares of 16,575 TScan Therapeutics, Inc. (NASDAQ:TCRX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Barbara Klencke , Timothyj Barberich , Holdings Channel , Stifel Financial Corp , Tscan Therapeutics Company Profile , Renaissance Technologies , Letko Brosseau Associates Inc , Tscan Therapeutics Inc , Securities Exchange Commission , Pale Fire Capital , Free Report , Financial Corp , Street Corp , Director Timothy , Exchange Commission , Director Barbara Klencke , Therapeutics Trading Down , Therapeutics Company , Visit Holdingschannel , Therapeutics Daily ,

Pale Fire Capital SE Makes New Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX)

Pale Fire Capital SE Makes New Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Timothyj Barberich , Barbara Klencke , Millennium Management , Exchange Commission , Tscan Therapeutics Company Profile , Renaissance Technologies , Securities Exchange Commission , Tscan Therapeutics Inc , Pale Fire Capital , Free Report , Street Group , State Street Corp , Street Corp , Director Timothy , Director Barbara Klencke , Therapeutics Stock , Therapeutics Company , Therapeutics Daily ,

Lifesci Capital Reiterates Outperform Rating for TScan Therapeutics (NASDAQ:TCRX)

Lifesci Capital Reiterates Outperform Rating for TScan Therapeutics (NASDAQ:TCRX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Monashee Investment Management , Asset Management Inc , Tscan Therapeutics Inc , Tscan Therapeutics Company Profile , Stifel Financial Corp , Privium Fund Management , Get Free Report , Lifesci Capital , Asset Management , Investment Management , Financial Corp , State Street Corp , Street Corp , Therapeutics Company , Therapeutics Daily ,